Herbalife Ltd. (NYSE:HLF – Get Free Report) Director Donal L. Mulligan purchased 30,000 shares of the firm’s stock in a transaction dated Friday, May 3rd. The shares were purchased at an average cost of $9.65 per share, for a total transaction of $289,500.00. Following the purchase, the director now directly owns 60,000 shares in the company, valued at $579,000. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.
Herbalife Price Performance
HLF stock traded up $0.42 during midday trading on Monday, hitting $10.00. The stock had a trading volume of 1,296,188 shares, compared to its average volume of 2,217,888. The company’s 50-day moving average price is $8.82 and its 200 day moving average price is $11.52. The firm has a market cap of $999.70 million, a PE ratio of 6.99 and a beta of 1.24. Herbalife Ltd. has a 12-month low of $6.68 and a 12-month high of $19.48.
Herbalife (NYSE:HLF – Get Free Report) last announced its quarterly earnings data on Wednesday, May 1st. The company reported $0.49 EPS for the quarter, beating analysts’ consensus estimates of $0.37 by $0.12. Herbalife had a negative return on equity of 19.97% and a net margin of 2.70%. The business had revenue of $1.30 billion during the quarter, compared to the consensus estimate of $1.26 billion. During the same quarter in the previous year, the business earned $0.54 earnings per share. The business’s revenue for the quarter was up 3.8% on a year-over-year basis. As a group, sell-side analysts anticipate that Herbalife Ltd. will post 1.69 EPS for the current year.
Institutional Investors Weigh In On Herbalife
Wall Street Analysts Forecast Growth
A number of research firms have commented on HLF. StockNews.com upgraded Herbalife from a “hold” rating to a “buy” rating in a research report on Friday, February 16th. Mizuho decreased their price objective on shares of Herbalife from $12.00 to $10.00 and set a “neutral” rating on the stock in a research report on Thursday, March 21st. Bank of America cut their target price on shares of Herbalife from $10.00 to $8.00 and set an “underperform” rating for the company in a research report on Thursday, March 21st. Finally, DA Davidson reaffirmed a “neutral” rating and issued a $9.50 price target on shares of Herbalife in a report on Thursday. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and one has issued a buy rating to the company’s stock. According to MarketBeat, Herbalife currently has an average rating of “Hold” and an average price target of $10.50.
Read Our Latest Research Report on Herbalife
Herbalife Company Profile
Herbalife Ltd. provides health and wellness products in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers products in the areas of weight management; targeted nutrition; energy, sports, and fitness; outer nutrition; and literature and promotional items.
Read More
- Five stocks we like better than Herbalife
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- 3 CEO-Led Turnaround Stocks You Can Still Buy
- How to Use the MarketBeat Stock Screener
- 3 Value Stocks You Can Buy Before They Become Big
- Breakout Stocks: What They Are and How to Identify Them
- Chinese Stocks Stage Impressive Rebound
Receive News & Ratings for Herbalife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Herbalife and related companies with MarketBeat.com's FREE daily email newsletter.